News
- Author:
- Sara Freeman
Publish date: November 8, 2023
Research over the past decade has also started to look at the potential role of the skin microbiome in the disease process, but answers have remain...
News
- Author:
- Sara Freeman
Publish date: November 2, 2023
"Now I hope you understand why we are so excited," said lead investigator Sonja Ständer, MD.
News
- Author:
- Sara Freeman
Publish date: November 2, 2023
Despite being approved in Europe, Oleogel-S10 has not yet been approved to treat EB in the United States.
News
- Author:
- Sara Freeman
Publish date: October 16, 2023
An “extraordinary” finding was how some patients’ weight status based on their BMI changed throughout the study.
News
- Author:
- Sara Freeman
Publish date: October 16, 2023
Coacillium cutaneous solution is also under investigation as a treatment for persistent chemotherapy-induced alopecia, atopic dermatitis, and psori...
News
- Author:
- Sara Freeman
Publish date: August 15, 2023
“Axial spondyloarthritis is one disease, and whether it is radiographic or nonradiographic makes zero difference in the management of the patient.”...
News
- Author:
- Sara Freeman
Publish date: August 14, 2023
Worldwide, the average time to diagnosis was found to be up to 6 years, but patient advocacy groups say the delay can be up to 10 years or more.
News
- Author:
- Sara Freeman
Publish date: June 1, 2023
Musculoskeletal symptoms identified in some patients treated with dupilumab for atopic dermatitis could help further understanding of how enthesiti...
News
- Author:
- Sara Freeman
Publish date: May 10, 2023
A new childhood version of the Lupus Low Disease Activity State has been purposefully developed to align with the criteria already used for adults....
News
- Author:
- Sara Freeman
Publish date: May 5, 2023
In about 5% of patients with seropositive RA, C-reactive protein levels were normal despite disease flares during a 5-year period. The findings rep...
News
- Author:
- Sara Freeman
Publish date: May 2, 2023
The results highlight the need for close monitoring and optimized multidisciplinary care for long-term adverse events after COVID-19 in patients wi...
News
- Author:
- Sara Freeman
Publish date: April 28, 2023
Among nearly one in four patients whose MRI results were initially positive for sacroiliitis, results were negative 6 weeks after NSAIDs were taken...
News
- Author:
- Sara Freeman
Publish date: April 26, 2023
Although no increased cancer risk was seen vs. methotrexate or placebo, Janus kinase inhibitors were associated with a higher cancer risk than were...
News
- Author:
- Sara Freeman
Publish date: April 25, 2023
There is no difference in the risk of myocardial infarction with interleukin-6 (IL-6) vs. anti–tumor necrosis factor (TNF) therapy for rheumatoid a...
News
- Author:
- Sara Freeman
Publish date: December 21, 2022
Guidelines could tailor cardiovascular risk scores by using a multiplier of 2.5 for systemic sclerosis, 2.0 for lupus, and 1.5 for any other rheuma...
